Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment

Multiple lines of evidence suggest a central role for the endocannabinoid system (ECS) in the neuronal development and cognitive function and in the pathogenesis of fragile X syndrome (FXS). This review describes the ECS, its role in the central nervous system, how it is dysregulated in FXS, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Joseph M., Thomas, Brian F., Budimirovic, Dejan, Siegel, Steven, Tassone, Flora, Hagerman, Randi, Faulk, Christopher, O’Quinn, Stephen, Sebree, Terri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830713/
https://www.ncbi.nlm.nih.gov/pubmed/36624400
http://dx.doi.org/10.1186/s11689-023-09475-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830713/
https://www.ncbi.nlm.nih.gov/pubmed/36624400
http://dx.doi.org/10.1186/s11689-023-09475-z

Ejemplares similares